Three Cancer Society-Funded Projects Relevant to Pancreatic Cancer

Among this year’s many research grants awarded by the Norwegian Cancer Society, three projects stand out for their relevance to pancreatic cancer and the development of future cancer treatments (Rekordtildeling til kreftforskning – Kreftforeningen).

Professor Caroline Verbeke (Oslo University Hospital) leads the project Lymph Node Metastases in Pancreatic Cancer: From Biology to Clinical Relevance. The research team will investigate why the spread of cancer to lymph nodes is associated with poorer survival in patients with pancreatic cancer. The goal is to understand how cancer cells, the immune system, and the lymph node microenvironment influence disease progression and the risk of recurrence, ultimately paving the way for more precise treatment and follow-up strategies.

Another project, led by Professor Tero Antero Aittokallio (Oslo University Hospital), focuses on personalized treatment of therapy-resistant pancreatic cancer. By combining artificial intelligence, single-cell analyses, and drug testing on patients’ own cancer cells, the researchers aim to identify the treatments most likely to benefit each individual patient.

The Norwegian Cancer Society has also awarded funding to the RADIATE project, led by Karine Flem Karlsen (University of Oslo). This project explores how cancer cells can be made more visible to the immune system, thereby enhancing the effectiveness of immunotherapy. Although not specifically focused on pancreatic cancer, the knowledge generated may ultimately have important implications for this disease as well.

Together, these projects represent important advances in research that could contribute to better treatments and improved survival for cancer patients in the years ahead.

The summary was created using AI, Oddmund Nordgård.